Induction of Dystrophin Expression by Exon Skipping in mdx Mice Following Intramuscular Injection of Antisense Oligonucleotides Complexed with PEG–PEI Copolymers
Open Access
- 1 July 2006
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 14 (1) , 88-96
- https://doi.org/10.1016/j.ymthe.2005.11.025
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Terminal antisense oligonucleotide modifications can enhance induced exon skippingNeuromuscular Disorders, 2005
- Targeted Exon Skipping in Transgenic hDMD Mice: A Model for Direct Preclinical Screening of Human-Specific Antisense OligonucleotidesMolecular Therapy, 2004
- Physicochemical and Biological Characterization of Polyethylenimine-graft-Poly(ethylene glycol) Block Copolymers as a Delivery System for Oligonucleotides and RibozymesBioconjugate Chemistry, 2004
- Antisense-Induced Multiexon Skipping for Duchenne Muscular Dystrophy Makes More SenseAmerican Journal of Human Genetics, 2004
- Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patientsHuman Molecular Genetics, 2003
- Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophyNeuromuscular Disorders, 2002
- Intracellular route and transcriptional competence of polyethylenimine–DNA complexesJournal of Controlled Release, 2002
- Vehicles for oligonucleotide delivery to tumoursJournal of Pharmacy and Pharmacology, 2002
- Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotidesHuman Molecular Genetics, 1998
- A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.Proceedings of the National Academy of Sciences, 1995